Jan. 30, 2024, 11:55 a.m. | Rob Thubron

TechSpot www.techspot.com


Back in May last year, Neuralink, founded by Musk in 2016, was given permission by the Federal Drug Administration (FDA) to begin its first in-human clinical study, paving the way for a brain-machine interface with the potential to treat fatal neurological diseases, paralysis, blindness, and more. In September, the brain...

Read Entire Article

administration blindness brain clinical diseases elon elon musk fda human implant machine musk neuralink neuralink implant paralysis patient september study

Data Architect

@ University of Texas at Austin | Austin, TX

Data ETL Engineer

@ University of Texas at Austin | Austin, TX

Lead GNSS Data Scientist

@ Lurra Systems | Melbourne

Senior Machine Learning Engineer (MLOps)

@ Promaton | Remote, Europe

Reporting & Data Analytics Lead (Sizewell C)

@ EDF | London, GB

Data Analyst

@ Notable | San Mateo, CA